Clinical Trials Logo

Mental Disorders clinical trials

View clinical trials related to Mental Disorders.

Filter by:

NCT ID: NCT01610011 Completed - Schizophrenia Clinical Trials

Acute Glycine Pharmacodynamic Study

Start date: July 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to use proton magnetic resonance spectroscopy (MRS) at 4 Tesla to measure brain glycine levels noninvasively at baseline and for 2 hours after a single oral dose of a concentrated glycine-containing beverage, and to compare MRS glycine measurements to glycine blood levels in samples obtained after each MRS spectrum. The investigators hypothesize that they will observe a high correlation between the magnitude increases in brain and plasma glycine levels over this time frame. The investigators also hypothesize that we will observe large intersubject variability in glycine uptake rates into brain and blood. The investigators also hypothesize that subjects with a glycine decarboxylase (GLDC) mutation (triplication) will have lower baseline plasma and brain glycine levels and will experience smaller brain and plasma glycine increases after glycine consumption than controls or family members without the GLDC mutation.

NCT ID: NCT01607086 Completed - Mental Disorders Clinical Trials

Compare the Properties and Characteristics of an Investigational Formulation of Lamotrigine With Placebo

Start date: July 11, 2008
Phase: Phase 1
Study type: Interventional

The objective of this sensory analysis study is to determine whether volunteers observe a significant difference in organoleptic properties between lamotrigine (430C78) cherry flavoured orally disintegrating tablets (ODT) and a placebo cherry flavoured orally disintegrating tablet. The aim is to assess the value of the placebo as a marketing aid, whereby physicians and patients may assess the personal acceptability of the organoleptic properties and potential convenience prior to prescription of the ODT formulation.

NCT ID: NCT01601587 Completed - Clinical trials for Mental Health Disorders

Introduction Seminar About Patient Participation and Treatment Options Decisional Preferences

Start date: May 2012
Phase: N/A
Study type: Interventional

Patient participation (PP) in Hospital is a goal defined by the Norwegian Health Authorities and it is a mandatory activity for District Psychiatric out-patient Centres (DPC) in Norway: patients are entitled to have influence on their treatment and should receive sufficient information directed at empowerment. Nevertheless, studies from Norway have found that patients who seek help are dissatisfied with the information they receive and doubt their possibility for real influence on their treatment. One way to improve individual PP might be to give patients sufficient information and education before they start their treatment in the form of an educational group intervention, an introduction seminar (IS); this group intervention is less time and resource consuming than individual interventions. Aims: The main purpose of this project is to develop and evaluate an IS for patients on a waiting list of DPC. The seminar will educate patients, so they can actively participate in their own treatment and, thereby, choosing treatment, reducing the risk of dropping out of treatment. Another aim is to enable patients to participate in their own treatment, to cope with their problems while they are waiting for treatment by providing them contact with primary health care and user organizations during their waiting time, and to increase adherence. Methods: The project involves three components: an exploratory study of educational content of the seminar; RCT of that 4-hours program (to examine its effect on treatment preferences and choices, activation, satisfaction, mental health and cost-benefit) and then a post-seminar qualitative evaluation, which will be used to create a broad yet deep understanding of the practical side of the participants`experience and the seminar's effect.

NCT ID: NCT01597141 Completed - Psychotic Disorders Clinical Trials

Psychosis: Early Detection, Intervention and Prevention

EDIP
Start date: May 2003
Phase: N/A
Study type: Interventional

The primary aim of this application is to conduct a randomized, controlled clinical trial of a specialized mental health service delivery system specifically developed for prodromal psychotic disorders. The intervention is Family-aided Assertive Community Treatment (FACT). The goal of the treatment is prevention of psychosis and disability. This study will assess experimentally the clinical effectiveness of this new type of mental health service. Other domains of outcome include cognitive dysfunction and functional disability.

NCT ID: NCT01579422 Completed - Schizophrenia Clinical Trials

Social Cognitive Training for Psychosis: Treatment Development

Start date: May 2012
Phase: Phase 1
Study type: Interventional

The primary aim of this proposal is to develop, refine, manualize and assess the feasibility and preliminary efficacy of a brief, narrowly-focused social cognitive intervention for individuals with psychosis. The intervention will focus on helping individuals interpret social situations, specifically the intentions and feelings of others. Study methods include preliminary treatment and manual development based on series of uncontrolled cases, manual refinement, and a small feasibility/efficacy trial of the newly developed intervention.

NCT ID: NCT01574703 Completed - Smoking Cessation Clinical Trials

Study To Evaluate Cardiac Assessments Following Different Treatments Of Smoking Cessation Medications In Subjects With And Without Psychiatric Disorders.

CATS
Start date: May 2012
Phase: Phase 4
Study type: Interventional

Non-treatment extension to study A3051123, aimed at collecting data on cardiovascular safety for all participants in the A3051123 trial for an additional 28 weeks, allowing for a total of 52 weeks of cardiovascular safety data collection.

NCT ID: NCT01570972 Completed - Schizophrenia Clinical Trials

Mediators and Moderators of Treatment Outcome in Recent-Onset Psychosis

Start date: February 2010
Phase: N/A
Study type: Interventional

Multifamily group psychoeducation [MFG] and group cognitive behavioral therapy [GCBT] are evidence-based treatments for first episode psychosis. However, like all treatments for psychotic disorders, neither MFG nor GCBT are perfect—some individuals who receive these interventions still experience a worsening of psychotic symptoms. Clarifying the mechanisms through which these interventions produce their clinical benefits and identifying the factors that may maximize an individual's response to MFG and GCBT could improve the clinical benefits facilitated by these two interventions.

NCT ID: NCT01569347 Completed - Clinical trials for Cocaine-induced Psychotic Disorder During Intoxication

Clinical and Genetic Factors Associated With Psychotic Symptoms Among Cocaine Abusers

PSYCHOCOKE
Start date: April 2012
Phase: N/A
Study type: Observational

The aim of this study is to determine the clinical, genetic and environmental factors associated with the phenotype "severe psychotic symptoms" caused by cocaine.

NCT ID: NCT01566513 Completed - Clinical trials for Serious Mental Illness

Effectiveness and Cost Effectiveness of Peer Mentors in Reducing Hospital Use

Project PEP
Start date: August 2011
Phase: N/A
Study type: Interventional

The current study, through a randomized controlled design, will evaluate the effectiveness of peer support, as compared to usual care and to an equivalent amount of support offered by peer case managers and non-peer recovery mentors, in reducing hospital days and readmissions and in promoting recovery and community inclusion among adults with mental illnesses with histories of multiple hospitalizations. The current study evaluates the cost-effectiveness of adding peer support to the array of services available to persons with serious mental illnesses who have histories of multiple hospitalizations and will test a theoretical model of the active ingredients of peer support, focusing specifically on the roles of 1) instillation of hope through positive self-disclosure; 2) role modeling of self-care and exploring new ways of using experiential knowledge; and 3) a trusting relationship characterized by acceptance, understanding, and empathy with conditional regard.

NCT ID: NCT01565863 Completed - Mental Disorders Clinical Trials

Progressive Goal Attainment Program for Veterans

PGAP for Vets
Start date: February 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to test the effectiveness of the Progressive Goal Attainment Program (PGAP) in improving employment outcomes and community engagement among U.S. veterans with disabilities.